94450 ⎘
Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems; Benzimidazoles; Hydrogenated benzimidazoles Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND, ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-EMITTING DEVICE, AND THE ORGANIC COMPOUND
#2COMPOUNDS
#3Resin and Method for Manufacturing Same
#4A TAUTOMERIC LIGAND ENABLES BIOMIMETIC C-H HYDROXYLATION WITH MOLECULAR OXYGEN
#5NUCLEIC ACID CROSSLINKING REAGENTS AND USES THEREOF
#6NOVEL SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND METHOD OF USE THEREOF
#7COMPOUNDS
#8HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION
#9ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME
#10NOVEL TERNARY MOLECULAR COMPLEX OF TAMIBAROTENE FOR CANCER STEM CELLS TREATMENT
#11TREATMENT OF ACANTHAMOEBA OR BALAMUTHIA TROPHOZOITES AND/OR CYSTS
#12Polymers derived from 2,2′-bisimidazoles
#13Organic electroluminescence device and polycyclic compound for organic electroluminescence device
#14ANTHRACENE DERIVATIVES CONTAINING BENZIMIDAZOLE OR BORATE AND ORGANOELECTROLUMINESCENT DEVICE INCLUDING THE SAME
#15Heterocyclic compounds for the treatment of arenavirus
#16Transcriptome-wide design of selective, bioactive small molecules targeting RNA
#17Bis-benzimidazole compounds and methods of using the same
#18PU.1 inhibitors
#19Organic light-emitting device
#20Organic light-emitting device
#21Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria
#22Methods of making 1,19-nonadecanediester and derivatives thereof
#23Protein kinase inhibitors
#24Organic light-emitting device
#25ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#26PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof
#27Organic EL device and display unit
#282,2′-bibenzo[D]imidazolidene compound having condensed rings at the 1-, 1′-, 3- and 3′-positions, and organic light-emitting element, display device, image information processing apparatus, lighting device, image forming apparatus and exposure unit, each containing the same
#29Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction
#30Tandem organic light-emitting diode, array substrate and display device
#312-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin E synthase inhibitors
#32Organic compound, field element, organic light-emitting element, display apparatus, image information-processing apparatus, lighting apparatus, image-forming apparatus, and exposure apparatus
#33Diphenylimidazole-fused, spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same
#34Spirally configured cis-stilbene/fluorene hybrid compounds and organic light emitting device comprising the same
#35Compound and organic electronic device using the same
#36Dibenzothiophene-containing materials in phosphorescent light emitting diodes
#37Benzimidazole derivatives as selective blockers of persistent sodium current
#38Blue luminescent compounds
#39MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#40Selective inhibition of bacterial topoisomerase I
#41AMINE DERIVATIVES, MATERIAL FOR ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME, AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME
#42Transcriptome-wide design of selective, bioactive small molecules targeting RNA
#43Fused polycyclic compound and organic light emitting element including the same
#44BIPHENYL DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE
#45Hematopoietic growth factor mimetic small molecule compounds and their uses
#46One pot process for the preparation of telmisartan
#47Nitrogen-containing heterocyclic compound and organic electronic device using same
#48Compounds, sensors, methods, and systems for detecting gamma radiation
#49Organic electronic material and organic electroluminescent device
#50Protein kinase inhibitors
#51Bipolar hosts for light emitting devices
#52Organic electric-field light-emitting element, light-emitting material for organic electric-field light-emitting element, and light-emitting device, display device, and illumination device using same element
#53Substituted aromatic oligomers
#54Antiviral Drugs for Treatment of Arenvirus Infection
#55Dibenzothiophene-containing materials in phosphorescent light emitting diodes
#56Capsule-type compound, anion removing agent, and method for removing anion
#57Benzimidazole derivatives as selective blockers of persistent sodium current
#58Process for manufacture of telmisartan
#59Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
#60Analogues for the treatment or prevention of flavivirus infections
#61COMPOUNDS FOR USE IN ELECTROLYTE FOR SOLAR CELL, METHOD FOR PREPARING THE SAME, AND ELECTROLYTE AND SOLAR CELL HAVING THE SAME
#62Dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes—useful or detection or quantification of desirable target molecules
#63Hematopoietic growth factor mimetic small molecule compounds and their uses
#64Angiotensin II receptor antagonists
#65PHOTOELECTRIC CONVERSION ELEMENT COMPRISING BINUCLEAR RUTHENIUM COMPLEX DYE HAVING SUBSTITUTED BIPYRIDYL GROUP, AND PHOTOCHEMICAL CELL
#66Materials for organic electroluminescent devices
#67Compositions useful for detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
#68ANTI-NEURODEGENERATIVE DISEASE AGENT
#69Dibenzothiophene-containing materials in phosphorescent light emitting diodes
#70Angiotensin II receptor antagonists
#71MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#72Anthracene derivative and an organic electronic device using the same
#732′-halobiphenyl-4-yl intermediates in the synthesis of angiotensin II antagonists
#74Catalyzed carbonylation in the synthesis of angiotensin II antagonists
#75Bicyclic heteroaryl compounds
#76Angiotensin II receptor antagonists
#77METHOD FOR TREATING NEUROLOGICAL DISORDERS WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS
#78Antiviral drugs for treatment of arenavirus infection
#79Angiotensin II receptor antagonists
#80Benzimidazole, Benzoxazole and Benzothiazole Derivatives, Optical Film Comprising them and Method of Producing thereof
#81Dyes linked to target molecules, oligonucleotides or polynucleotides comprising dye molecules, composite dyes and other compositions useful for detecting or quantifying desirable target molecules
#82Nitrogen containing heterocycle derivative and organic electroluminescent element using the same
#83Liquid crystal display operating in a vertically aligned mode
#84Hepatitis C virus inhibitors
#85Methods for detecting the presence, location or quantity of targets using novel dyes
#86Radioprotector compounds and related methods
#87Chromophore Coated Metal Oxide Particles
#88Dibenzothiophene-containing materials in phosphorescent light emitting diodes
#89Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof
#90Process for the preparation of Telmisartan
#91Preparation of Telmisartan Salts with Improved Solubility
#92Cardiovascular Compounds Comprising Nitric Oxide Enhancing Groups, Compositions and Methods of Use
#93Thin-film materials, thin films and producing method thereof
#94Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same
#95Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
#96Heterocyclic compounds useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders
#97UV filters
#98Technetium- and rhenium-bis (heteroaryl) complexes, and methods of use thereof
#99Process for the preparation of telmisartan
#100Heterocyclic topoisomerase poisons
#101Process for preparing telmisartan
#102Dicationic Compounds For Activity Against Trichomonas Vaginalis
#103Process for the preparation of bis-benzazolyl compounds
#104Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same
#105Cell targeting conjugates
#106Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
#107Novel amidine compounds for treating microbial infections
#108Bis-benzimidazoles and related compounds as potassium channel modulators
#109Amorphous and polymorphic forms of telmisartan sodium
#110Crystalline Form of Telmisartan Sodium
#111Processes of preparing highly pure telmisartan form A, suitable for pharmaceutical compositions
#112Nitoroxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
#113Dyes for the detection or quantification of desirable target molecules
#114Process for the preparation of telmisartan
#115Telmisartan production process
#116Process for the preparation of angiotensin receptor blockers and intermediates thereof
#117Bis-heterocyclic compounds with antitumour and chemosensitising activity
#118Nitrogen-containing heterocycle derivative and organic electroluminescent element using the same
#119Esters of aryl benzimidazole sulfonic acids and sunscreen compositions containing same
#120Novel PPAR agonists, pharmaceutical compositions and uses thereof
#121Thermosetting polyimides derived from resveratrol
#122Thermosetting polyimides derived from resveratrol
#123Spirally configured cis-stilbene/fluorene hybrid materials as hole-blocking type electron-transporters for OLED